Home › Funds › T. Rowe Price Associates › ABBV
T. Rowe Price Associates position in ABBV
ABBVIE INC · Health Care
Latest position (Q2 2026)14.75M sh
Reported value held$3.71M
Portfolio Weight0.39%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 26.21M | $2.83B | New |
| Q4 2021 | 32.59M | $4.41B | Add |
| Q1 2022 | 36.73M | $5.95B | Add |
| Q2 2022 | 30.81M | $4.72B | Reduce |
| Q3 2022 | 24.52M | $3.29B | Reduce |
| Q4 2022 | 20.42M | $3.30M | Reduce |
| Q1 2023 | 17.58M | $2.80M | Reduce |
| Q2 2023 | 13.16M | $1.77M | Reduce |
| Q3 2023 | 12.81M | $1.91M | Reduce |
| Q4 2023 | 9.45M | $1.46M | Reduce |
| Q1 2024 | 10.74M | $1.96M | Add |
| Q2 2024 | 10.94M | $1.88M | Add |
| Q3 2024 | 10.26M | $2.03M | Reduce |
| Q4 2024 | 10.19M | $1.81M | Reduce |
| Q1 2025 | 7.19M | $1.51M | Reduce |
| Q2 2025 | 9.06M | $1.68M | Add |
| Q3 2025 | 10.60M | $2.45M | Add |
| Q4 2025 | 9.83M | $2.25M | Reduce |
| Q1 2026 | 13.00M | $2.83M | Add |
| Q2 2026 | 14.75M | $3.71M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ABBV
- Vanguard Group 180.78M sh · $41.31B · Q4 2025
- BlackRock Inc 149.49M sh · $37.62B · Q2 2026
- Geode Capital Management 47.00M sh · $11.81B · Q2 2026
- Morgan Stanley 38.90M sh · $9.79B · Q2 2026
- Capital Research Global Investors 30.10M sh · $7.57B · Q2 2026
- Norges Bank Investment Management 25.55M sh · $6.43B · Q2 2026
- Bank of America Corp 21.24M sh · $5.34B · Q2 2026
- Fidelity Management & Research (FMR) 20.77M sh · $5.23B · Q2 2026
- Northern Trust Corp 20.56M sh · $5.17B · Q2 2026
- Franklin Resources 19.93M sh · $5.01B · Q2 2026
- Capital World Investors 19.18M sh · $4.83B · Q2 2026
- Goldman Sachs Group 17.74M sh · $4.46B · Q2 2026